— Know what they know.
Not Investment Advice

KZR NASDAQ

Kezar Life Sciences, Inc.
1W: -1.4% 1M: -1.1% 3M: +18.5% YTD: +15.9% 1Y: +76.9% 3Y: -97.2% 5Y: -98.7%
$7.29
Last traded 2026-05-11 — delisted
NASDAQ · Healthcare · Biotechnology · $53.9M mcap · 6M float · 1.44% daily turnover · Short 24% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-45M
Net Income
+42.5% YoY
$-42M
Free Cash Flow
+38.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-53.8%
ROA-46.8%
ROIC-9167.1%

Valuation

P/E-1.2
P/B0.8
EV/EBITDA0.3

Leverage

Debt/Equity0.02
Current Ratio24.46
Interest Cov.-68.0x

Quality Scores

Piotroski F4/9
Altman Z1.16
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms